Literature DB >> 19282089

Phase-plot analysis of the oxytocin effect on human myometrial contractility.

Joanna E Gullam1, Andrew M Blanks, Steven Thornton, Anatoly Shmygol.   

Abstract

OBJECTIVE: Analysis of uterine contractility in vitro is usually confined to measuring a few traditional parameters of uterine contractility, such as contraction amplitude, frequency and area under the curve. In this paper, we describe parameters that provide additional information obtained from the traces of force and its first derivative. We propose an improved contractility index which is less dependent on variability between samples. STUDY
DESIGN: Standard organ bath recording of myometrial contractions in the presence or absence of oxytocin on samples of human myometrium obtained from 26 patients at Caesarean section. The parameters were obtained from the plots of first derivative vs. contractile force (phase portrait plot). RESULTS AND
CONCLUSIONS: Oxytocin (1nM) significantly increased the contraction amplitude (Fmax), area under the curve, maximum rate of contraction (CVmax), decreased the maximum rate of relaxation (RVmax) and had no statistically significant effect on the duration of contraction (measured as full width at half amplitude, W50). In addition to the above effects, 10nM oxytocin increased the contraction duration (P=0.0036, n=24). The fraction of force developed at the time of CVmax showed no change at any concentration of oxytocin, while the fraction of force remaining at RVmax was decreased in a dose dependent manner. The least variable (i.e. showing lowest P values in paired Student's t-Test) parameters were the Fmax and CVmax/RVmax. When non-paired t-Test was applied, P value of the CVmax/RVmax remained low, while the variability of Fmax increased reflecting the sample-to-sample variations. The product of the Fmax and CVmax/RVmax, which we propose as uterine contractility index (CI) showed low P values in both paired and non-paired t-Tests. We conclude that the phase plot analysis provides useful additional information on contraction/relaxation properties of human myometrium and the CI is suitable for characterising the contractility of uterine samples with different connective tissue content.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19282089     DOI: 10.1016/j.ejogrb.2009.02.020

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  2 in total

1.  Expression of gastrin-releasing peptide is increased by prolonged stretch of human myometrium, and antagonists of its receptor inhibit contractility.

Authors:  Mark Tattersall; Yolande Cordeaux; D Stephen Charnock-Jones; Gordon C S Smith
Journal:  J Physiol       Date:  2012-03-12       Impact factor: 5.182

2.  Hyponatraemia reversibly affects human myometrial contractility. An in vitro pilot study.

Authors:  Vibeke Moen; Lars Brudin; Anette Ebberyd; Maria Sennström; Gunvor Ekman-Ordeberg; Mats Rundgren; Lars Irestedt
Journal:  PLoS One       Date:  2020-01-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.